Program

Registration

Opening of ANZTCT ASM

Chairs: A/Prof Nada Hamad and Dr Duncan Purtill

• Welcome to Country - Brendan Kerin
• Maori Address - Nadene Edmonds
• President's Address

GVHD at the extremes of age

Chairs: A/Prof Nada Hamad and Dr Duncan Purtill

• Prof Paul Carpenter - Fred Hutchinson Cancer Centre

PTCY in adults and paeds: Why and how of PTCY

Chairs: A/Prof Nada Hamad and Dr Duncan Purtill

• A/Prof Heather Symons - John Hopkins Children’s Center

Morning Tea

Sponsored by Ontime Couriers GmbH

Plenary BMT Abstracts

Chairs: Dr Clinton Lewis and Yvonne Panek-Hudson

• Min-Hi Han - Incidence, characteristics and organ involvement of chronic graft-versus-host disease measured by continuous National Institutes of Health consensus assessment
• Heather Dunckley - HLA-DPB1 protein expression in haematopoietic cell transplant patients in New Zealand
• Alia Cibich - Secondary malignancy after allogeneic haematopoietic stem cell transplant in adults: a single-centre registry analysis?

Lunch ‘n’ Learn (12:50pm – 1:30pm)

Sponsored by Mallinckrodt Pharmaceuticals
Chairs: Yvonne Panek-Hudson and Alex Rivalland
Prof Paul Carpenter: The importance of diagnosing and managing GVHD early

Infection/Vaccination

Chairs: Andrea Henden and A/Prof Emily Blyth

• Dr Ben Teh - Peter MacCallum Cancer Centre

Future of Microbiome in TCT

Chairs: Dr Andrea Henden and A/Prof Emily Blyth

• Dr Craig Haifer - St Vincent's Hospital Sydney

Oral Abstracts

Chairs: Dr Andrea Henden and A/Prof Emily Blyth

• Phillip Selby - Optimising antifungal prophylaxis in allogeneic stem cell transplantation – a cohort study of two different approaches
• Phillip Selby - Population Pharmacokinetics of Ganciclovir in Allogeneic Hematopoietic Stem Cell Transplant Patients
• Gaurav Sutrave - Third-party partially HLA matched fungus-specific T-cells can lead to clearance of invasive fungal infections in patients post-allogeneic bone marrow transplantation

Afternoon Tea

Sponsored by Ontime Couriers GmbH

Oral Abstracts

Chairs: Annette Trickett and John Coutsouvelis

• Nienke Zomerdijk - Developing a psycho-educational resource for family stem cell donors
• Julian Cooney - Optimising Bone Marrow Harvests: NMDP Mentorship & USA Centre of Excellence
• Katie Jessen - Autologous stem cell mobilisation and transplant following bortezomib, lenalidomide and dexamethasone in multiple myeloma: single-centre experience
• Aleece MacPhail - Post Allograft Immunoglobulin Replacement Study (PAIRS): protocol for an observational cohort study

Arrow Foundation Data Manager/QM Breakfast (by invitation)

Registry data at the core of clinical quality and service planning

The importance and value of registry: CIBMTR perspectives

Chairs: Prof Peter Shaw and A/Prof Glen Kennedy

• Prof Bronwen Shaw - Medical College of Wisconsin (supported by ABMDR)

Value of (FACT/JACIE )Accreditation and improving patient outcomes

Chairs: Prof Peter Shaw and A/Prof Glen Kennedy

• Dr Andrea Henden - Royal Brisbane Hospital

Update on the Australian Commission on Safety and Quality in Health Care Clinical Quality Registry Program

Chairs: Prof Peter Shaw and A/Prof Glen Kennedy

• Mr Suchit Handa - Program Director, Safety and Quality Improvement Systems

Update from the Te Tāhū Hauora Health Quality & Safety Commission: Indigenous data Sovereignty

Chairs: Prof Peter Shaw and A/Prof Glen Kennedy

• Peter Jansen - Chief Executive, NZ HQSC

Morning Tea

Sponsored by Ontime Couriers GmbH

Registry update

Chairs: Prof Peter Shaw and A/Prof Glen Kennedy

• Leonie Wilcox - ANZTCT Registry

Panel Discussion: Future of Registry in TCT

Moderated by Prof Peter Shaw:
Panelists:

• Prof Bronwyn Shaw
• Suchit Handa
• Peter Jansen
• Leonie Wilcox
• A/Prof Glen Kennedy

Registry Research Proposals Announcement of ARROW scholarships for ANZTCT Registry disease specific outcomes projects

Chairs: Prof Jeff Szer and Richelle Koller

Lunch ‘n’ Learn (from 1:00pm)

Sponsored by JazzPharma
Chair: Dr Ian Bilmon
John Coutsouvelis: VOD in ANZ and the new EBMT guidance and upcoming ANZTCT guidance

Whole CART Community Clinical Practice Session

Neurotx management

Chairs: Prof Joy Ho and Kari Mudie

• Prof Cameron Turtle - The University of Sydney

CART debate - Is autograft in Lymphoma and Myeloma Dead?

Chairs: Prof Joy Ho and Kari Mudie

• Lymphoma: Dr Nausheen Ahmed (University of Kansas) Affirmative Vs Dr Ed Abadir (RPA Hospital) Negative
• Myeloma: Dr Nausheen Ahmed (University of Kansas) Affirmative Vs Dr Fiona Kwok (Westmead Hospital) Negative

Afternoon Tea

Sponsored by Ontime Couriers GmbH

Plenary CT Abstracts

Chairs: Dr Rob Weinkove and Dr Duncan Purtill

• Dr Ed Abadir: National CART Adult outcome Data
• A/Prof Adam Nelson: National Paediatric outcome Data
• Rebecca Wayte: Phenotyping CAR T-cells early post infusion reveals better clinical response rates for patients with high expression of PD1 on CD8 CAR T-cells
• Dr Nausheen Ahmed: Real-world outcomes of brexucabtagene autoleucel (brexu-cel) for relapsed or refractory(R/R) mantle cell lymphoma (MCL): A CIBMTR subgroup analysis by prior treatment

Delegate break

Registration

Beyond the Cells: The future and sustainability of TCT

Donor sourcing - how that really works!

Chairs: Cushla Lucas and Carolyn Crump

• Lisa Smith - ABMDR

How far can we mismatch to improve access to donors?

Chairs: Dr Myra Ruka and Carolyn Crump

• Prof Bronwen Shaw - Medical College of Wisconsin (supported by ABMDR)

Access and Equity, Diversity and Inclusion in TCT

Chairs: Dr Nausheen Ahmed and Cushla Lucas

• Intersectionality in TCT: A/Prof Nada Hamad
• Indigenous Perspective: Prof Maree Toombes
• Indigenous Perspective: Dr Myra Ruka
• Initiatives to support equity of access to CAR T cell therapies: Rob Weinkove

What it takes to support TCT patients: Patient and family Perspectives

Chairs: A/Prof Adam Nelson and Dr Anna Johnston
Speakers:

• Patient: Josh Polon
• Parent: Hazel Polon

Morning Tea

Sponsored by Ontime Couriers GmbH

Panel: The future of TCT in ANZ: Policy design and strategic planning

Workforce planning/Facilities/Health economics/Funding
Moderated by A/Prof Nada Hamad
Panelists:

• Prof Bronwen Shaw - Medical College of Wisconsin (supported by ABMDR)
• Peter Jansen - NZ HQSC
• Paul Fennessy - Previously Department of Health Victoria
• A/Prof Glen Kennedy - Royal Brisbane Hospital
• Prof Maree Toombes - The University of Sydney
• Annette Trickett - Cellular therapy scientist

Heads of TCT units Networking Lunch (by invitation)

Beyond the Cells: Survivorship

Chairs: Dr Shahrukh Hashmi and Chris Murray

Late BMT complications 1

• Megan Hogg - Westmead Hospital Sydney

Late BMT complications 2

• Nicole Loft - SA Health

Cognition in survivorship

• Priscilla Gates - Deakin University

Nutrition in CAR-T

• Danika Carty - Peter MacCallum Cancer Centre

Exercise in survivorship

• Dr Shaza Abo - Peter MacCallum Cancer Centre

Afternoon Tea

Sponsored by Ontime Couriers GmbH

Graft versus Host Disease

• Alex Rivalland - Royal Melbourne Hospital

Vaccinations

• Trish Joyce - Peter MacCallum Cancer Centre